NOVEL CYCLOPROPABENZOFURANYL PYRIDOPYRAZINEDIONES

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein X, R1, R2a, R2b, R4a, R4b, R5a, R5b, R6, R7, R10, R11, and y are as defined in the specification. Corresponding pharmaceutical compositions, methods of trea...

Full description

Saved in:
Bibliographic Details
Main Authors Gregory Wayne KAUFFMAN, Patrick Robert VERHOEST, Martin Youngjin PETTERSSON, Antonia Friederike STEPAN, Christopher William AM ENDE, Douglas Scott JOHNSON
Format Patent
LanguageEnglish
Spanish
Published 24.10.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein X, R1, R2a, R2b, R4a, R4b, R5a, R5b, R6, R7, R10, R11, and y are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. Se describen compuestos y sales farmacéuticamente aceptables de los compuestos en donde los compuestos tienen la estructura de la Fórmula I (ver Fórmula) en donde X, R1, R2a, R2b, R4a, R4b, R5a, R5b, R6, R7, R10, R11, e y son como se definen en la especificación. También se describen las composiciones farmacéuticas correspondientes, métodos de tratamiento, métodos de síntesis, e intermediarios.
Bibliography:Application Number: MX20170010019